News

Please explore our newly added and updated NGS service from Quick Biology in 2019 including tissue ATAC-seq, RNA/DNA Methylation Analysis, 10X Chromium Single Cell Sequencing, low-input / single cell WGS, NGS-based HLA and ABO Typing, Liquid Biopsy, Immune Repertoire Profiling, and Cancer Panels

There are over 6,000 known rare diseases, many or a significant portion of which affect children’s development and can be traced to changes, or mutations in a single gene. These rare genetic diseases affect an estimated 30 million Americans. Thanks to advances in genome sequencing (NGS), more and more families are receiving an accurate diagnosis for their children’s condition, NGS is having changed diagnostic workflows and provided an unprecedented, simple way of discovering novel disease-associated genes.

Biomarker is vital for disease diagnosis and prognosis. One “biomarker” can be a protein, a metabolite, an RNA molecule or even a DNA mutation. Genomics is transforming every area of life science, next-generation sequencing (NGS) is a high-throughput genome sequencing technology, have now become mainstream in biomarker discovery.

In adult neurogenesis, there is very little knowledge about the embryonic origin and developmental process that leads to the establishment of adult neural progenitors in the mammalian brain. Scientists once thought that adult neurogenesis is from a specialized population of neural stem cells and they are different from the precursors generating neurons during embryo development. But a group of researchers from University of Pennsylvania, Philadelphia found that a single lineage of neural progenitors contributes to embryonic, early postnatal, and adult neurogenesis in the mice hippocampus.